RxDoctor Payments Data

Gina Zigerelli

Podiatrist · Manassas, VANPI 1164912358

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,786 of the $2,868 with a category attached, or 62.3%. 15 manufacturers reported payments, led by Mid-atlantic Surgical Systems, LLC at 30.2% of the total.

$2,868in general payments, 2019–2025

Across 43 payments — averaging $66.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mid-atlantic Surgical Systems, LLC$865
  • Treace Medical Concepts, Inc.$633
  • Smith+Nephew$588
  • Organogenesis Inc.$166
  • Medtronic$163
  • Amgen$132
  • plus $320 from 9 others

What the payments were for

  • Travel & lodging$2168%
  • Food & beverage$1,78662%
  • Education$86530%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,868 in reported general payments places this provider in the 70th percentile of 126 podiatrist providers in Virginia.

See all podiatrist providers in Virginia

Medicare billing

Part B allowed, 2024
$149,625
Medicare patients
568
Services billed
2,186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox54$2,656
Ketoconazole52$1,092
Meloxicam94$414
Ammonium Lactate15$403
Doxycycline Hyclate25$258
Methylprednisolone25$165

Paid to pharmacies, not to this prescriber.

Other podiatrist in Manassas

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →